2018 Program & Faculty

2018 Program & Faculty

The following is archived information from last January's symposium, AF2018, in Orlando, FL. Planning for AF2019 is well underway. Please check back periodically for details regarding the upcoming AF2019 in Boston.





Morning Scientific Session



7 - 7:10 a.m.          



Jeremy Ruskin, MD



7:10 - 9:20 a.m.



Moderators: Natalia Trayanova, PhD and Stanley Nattel, MD

All lectures 15 minutes and 5-minute Q&A


Aging, Inflammation and Atrial Fibrillation

Jose Jalife, MD


Fibrosis and AF: Insights from Patient-Specific Computational Simulations and Implications for AF Ablation

Natalia Trayanova, PhD


Lean Body Mass as a Common Denominator Connecting Treatable Risk Factors to AF: Evidence and Potential Significance

Stanley Nattel, MD


Linking AF Genetics to New Mechanisms: Are AF Associated Genes Potential Drug Targets?

Patrick Ellinor, MD, PhD


Novel Upstream Targets for AF from Genomics/Transcriptomics

Mina Chung, MD


Panel and Audience Q&A and Discussion - All Faculty (30 minutes)

Moderator: Jose Jalife, MD



9:20 - 9:50 a.m.





9:50 a.m. - Noon



Moderators: Elaine Hylek, MD, MPH and Daniel Singer, MD

All lectures 15 minutes and 5-minute Q&A


Current Status of Screening for AF: Frequency, Significance and Limitations of AHREs; How Much Should We Screen?

John Camm, MD


Real-World Data On NOACs and AF: How Is It Generated and What Does It Mean? and Future Trials on Stroke Prevention in AF

Daniel Singer, MD


Factor XIa Inhibitors: A New Class of Anticoagulants with Less Thrombus and Less Bleeding

Elaine Hylek, MD, MPH


Understanding High Intracranial Hemorrhage Risk: Biomarkers and Challenges in Management

M. Edip Gurol, MD


Can Anticoagulation Be Stopped After AF Ablation?

Yes: Francis Marchlinski, MD

No: Elaine Hylek, MD, MPH

(Each speaker 10 minutes; additional comments during panel discussion)


Panel and Audience Q&A and Discussion - All Faculty (30 minutes)

Moderator: John Camm, MD



Noon - 1:15 p.m.  








Afternoon Scientific Session



1:15 - 3:35 p.m.



Moderators: Dhanunjaya Lakkireddy, MD and Jacqueline Saw, MD

All lectures 15 minutes and 5-minute Q&A; case transmissions 30 minutes each


LAA Closure: Current State of the Art and Future Directions

Jacqueline Saw, MD


Case Transmissions - LAA Closure Procedures

Moderator: Vivek Reddy, MD


LAA Closure with ICE Guidance

Claudio Tondo, MD, PhD - Milan, Italy


New Technology for LA Appendage Closure

Tom De Potter, MD - Aalst, Belgium


Anticoagulation After LAA Closure: State of the Art and Future Directions

Vivek Reddy, MD


Role of Octreotide in LAA Closure in Patients with GI Bleeding

Dhanunjaya Lakkireddy, MD


FDA Perspectives on Left Atrial Appendage Occlusion Trials: Transforming Data into Evidence

Andrew Farb, MD



3:35 - 4:05 p.m.





4:05 - 4:55 p.m.



Moderator: David Keane, MD, PhD

Each lecture 10 minutes


Endocardial LAA Closure

Jacqueline Saw, MD


Epicardial LAA Closure

Dhanunjaya Lakkireddy, MD


Apixaban 5mg B.I.D.

Peter Kowey, MD


Panel and Audience Q&A and Discussion - All Faculty (20 minutes)

Moderator: David Keane, MD, PhD



4:55 - 6:15 p.m.



Panel and Audience Discussion (10 minutes per case)

Moderator: Eric Prystowsky, MD

Panel: Mina Chung, MD, Peter Kowey, MD, Eric Prystowsky, MD and Jeremy Ruskin, MD 



6:15 p.m.









Morning Scientific Session



7 - 9:10 a.m.



Moderator: Ulrich Schotten, MD, PhD

All lectures 15 minutes and 5-minute Q&A


A Cascade of Accelerating Rotors Precedes Stabilization of Early AF

Jose Jalife, MD


Atrial Myocardial Fiber Orientation In Human Autopsy Hearts: Implications for Transmural Breakthrough, 3-D Reentry and the Role of the LAA

David Keane, MD, PhD


3-D Computer Modelling of Endo-Epicardial Dissociation and Transmural Conduction in AF Using High Density Mapping 

Ulrich Schotten, MD, PhD


Atrial Fibrosis: Distribution, Extent and Clinical Characteristics as Predictors of Outcome of AF Ablation - Time for a Fundamental Change in Strategy?

Hans Kottkamp, MD


Atrial Fibrosis: A New Marker for Major Cardiovascular Events

Nassir Marrouche, MD


Panel and Audience Q&A and Discussion - All Faculty (30 minutes)

Moderator: Ulrich Schotten, MD, PhD



9:10 - 9:40 a.m.





9:40 a.m. - 12:40 p.m.



Moderators: Pierre Jais, MD and David Wilber, MD

All lectures 15 minutes and 5-minute Q&A; case transmissions 30 minutes each


Relation Between Rotors and Anatomical Obstacles During Atrial Fibrillation

Sanjiv Narayan, MD, PhD


Identification of AF Drivers and Endpoints for Ablation Using Multielectrode Catheters in Persistent AF

Michel Haissaguerre, MD


Complex Atrial Tachycardias Unmasked by Ultra High Density Mapping

Pierre Jais, MD


Beyond PV Isolation: Randomized Clinical Trials of Adjunctive Ablation Strategies for Persistent Atrial Fibrillation (AMAZE, DECAAF II, REAFFIRM)

David Wilber, MD


In What Types of AF Should LA Appendage Ablation Be Considered? Evidence and Patient Selection

Andrea Natale, MD


Case Transmissions - Techniques for Left Atrial Appendage Electrical Isolation as Adjunctive Therapy to PV Isolation in Persistent AF


Bradley Knight, MD - Chicago, IL


Rodney Horton, MD and Andrea Natale, MD - Austin, TX


New Approaches to Modulation of the Autonomic Nervous System in AF: Visualization and Ablation of Ganglionated Plexi

Evgeny Pokushalov, MD, PhD



12:40 - 1:55 p.m.








Afternoon Scientific Session



1:55 - 3:55 p.m.



Moderator: Moussa Mansour, MD

All lectures 15 minutes and 5-minute Q&A; case transmissions 30 minutes each


Real-Time Lesion Formation and Gap Detection During Ablation of Atrial Fibrillation Using Novel Electro-Anatomical Dielectric Mapping System: 12 Month Follow-Up

Evgeny Pokushalov, MD, PhD


Case Transmission - Lesion Assessment

Petr Neuzil, MD and Vivek Reddy, MD - Prague, Czech Republic


Case Transmission - New Techniques for Esophageal Protection

Kevin Heist, MD, PhD, Conor Barrett, MD, and Moussa Mansour, MD - Boston, MA


HEAT-AF: First Clinical Study On Effects A New Infrared Thermography Probe for Esophageal Protection

Thomas Deneke, MD


Randomized Evaluation of Atrial Fibrillation Treatment with Focal Impulse and Rotor Modulation Guided Procedures (REAFFIRM): Interim Analysis

Johannes Brachman, MD



3:55 - 4:25 p.m.





4:25 - 6:35 p.m.



Moderator: Karl-Heinz Kuck, MD


Prospective Non-Randomized FDA IDE Trial on a New Technology for Localizing Rotors and Focal Drivers of AF

Vivek Reddy, MD


Global Multi-Electrode Contact Mapping and Ablation of AF with a Single Catheter - First Human Experience

Hans Kottkamp, MD


Temperature Controlled Irrigated RF Ablation: Technology and Results

Moussa Mansour, MD


New RF Balloon Technologies for AF Ablation - Results of Multicenter Clinical Studies

Karl-Heinz Kuck, MD


Pulsed Electric Field Ablation: Preclinical Studies Assessing Safety and Efficacy

David Haines, MD


Panel and Audience Q&A and Discussion - All Faculty (30 minutes)

Moderator: Karl-Heinz Kuck, MD


6:35 p.m.









Morning Scientific Session



7 - 9:30 a.m.



Moderator: Douglas Packer, MD

All lectures 15 minutes and 5-minute Q&A


Clinical Trials of New Technologies in AF Ablation: 2018 Update 

Hugh Calkins, MD


2017 HRS/EHRA/ECAS/APHRS/SOLAECE Consensus Document on AF Ablation: Implications for Patient Care and Research 

Hugh Calkins, MD


Clinical Trials in AF Ablation: What Will CABANA Show and Will It Matter?

Douglas Packer, MD


Regulatory Challenges and Future Directions in AF Ablation Device Development and Evaluation

Mark Fellman


Does AF Ablation Improve Mortality in Congestive Heart Failure: New Insights from the CASTLE-AF Trial

Nassir Marrouche, MD


Ablation Strategies in Patients with AF and Congestive Heart Failure: Practical Considerations and Outcomes

Luigi Di Biase, MD, PhD


Panel and Audience Q&A and Discussion - All Faculty (30 minutes)

Moderator: Douglas Packer, MD



9:30 - 10 a.m.





10 a.m. - 12:10 p.m.



Moderator: Young-Hoon Kim, MD, PhD

All lectures 15 minutes and 5-minute Q&A


Characteristics and Ablation Outcomes in Early Onset AF: Role of One-Year Follow-Up Atrial MR Imaging

Young-Hoon Kim, MD, PhD


High Power Short Duration RF Ablation: Safety and Efficacy - Multicenter Experience

Pierre Jais, MD


What To Do After Three Failed AF Ablations?

Andrea Natale, MD


How to Improve the Speed and Efficiency AF Ablation While Maintaining Safety and Effectiveness

Rob Patrawala, MD


Big Data, Social Media and Monitoring: Optimizing Patient Outcomes in AF

Kevin Campbell, MD


Panel and Audience Q&A and Discussion - All Faculty (30 Minutes)

Moderator: Young-Hoon Kim, MD, PhD



12:10 - 12:30 p.m.



Moderators: Jeremy Ruskin, MD and Albert Waldo, MD



12:30 - 1:45 p.m. 








Afternoon Scientific Session



1:45 – 3:15 p.m.



Panel and Audience Discussion (10 minutes per case)

Moderator: Pierre Jais, MD 

Panel: Pierre Jais, MD, Young-Hoon Kim, MD, PhD, Moussa Mansour, MD, Andrea Natale, MD and Vivek Reddy, MD



3:15 p.m.










Massachusetts General Hospital, Boston, MA

Dr. Barrett, clinical director, Cardiac Arrhythmia Service, Massachusetts General Hospital, received his BMedSc, MB BCh BAO degrees from the National University of Ireland, Cork. He completed his surgical and medical internships, and subsequently completed his internal medicine residency in Cork University Hospital. His cardiology fellowship training in Ireland was supervised and overseen by the Royal College of Physicians, Ireland. He then completed two years of fellowship training in cardiac electrophysiology at Cleveland Clinic, Ohio. Dr. Barrett joined the staff of the Cardiac Arrhythmia Service at Massachusetts General Hospital in 2008. His main clinical and research interests focus on catheter ablation of cardiac arrhythmias, particularly ventricular tachycardia (VT), atrial fibrillation (AF), and other supraventricular tachycardias (SVTs). Dr. Barrett also performs implantation and follow-up of cardiac devices therapy including pacemakers, Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy (CRT) devices. He also performs LASER assisted extractions of implanted cardiac devices.



Johns Hopkins Medical Center, Baltimore, MD

Dr. Calkins, director of the Electrophysiology Laboratory and Arrhythmia Service at Johns Hopkins Hospital and The Nicholas J. Fortuin M.D. Professor of Cardiology, is internationally recognized as an expert on catheter ablation, atrial fibrillation, syncope, and arrhythmia management. Dr. Calkins has published more than 600 articles and book chapters on a large variety of cardiac arrhythmias. His research has focused predominantly on catheter ablation, atrial fibrillation, syncope, and arrhythmogenic right ventricular dysplasia. Dr. Calkins has also written extensively on most aspects of heart rhythm disorders and their treatment. He was the lead author on the 2007, 2012, and 2017 Consensus Document on Catheter and Surgical Ablation of Atrial Fibrillation. He is a past president of the Heart Rhythm Society.



St. George’s Medical School, London, United Kingdom

John Camm is Professor of Clinical Cardiology at St. George’s Hospital Medical School, University of London, UK, and Professor of Cardiology at Imperial College, London. His interests include cardiac arrhythmias, atrial fibrillation, stroke prevention, anticoagulation, clinical cardiac electrophysiology, cardiac pacemakers, and risk stratification in post-myocardial infarction, heart failure and cardiomyopathy. He is currently president of the European Heart Rhythm Association. Prof. Camm is president of a major UK charity, Arrhythmia Alliance, and co-founded another highly successful medical charity, the Atrial Fibrillation Association. He is editor-in-chief of Europace and Clinical Cardiology, editorial board member of another 15 journals, and an editor of the European Society of Cardiology Textbook of Cardiovascular Medicine. Prof. Camm has been involved in the production of numerous guidelines, including the ESC guidelines for the Management of Atrial Fibrillation (chair), the ACC/AHA/ESC guidelines on Ventricular Arrhythmias and Sudden Cardiac Death (chair), and Supraventricular Arrhythmias (member) and the NICE guidelines for the treatment of unstable angina and non-ST elevation ACS (chair), Atrial Fibrillation (member) and Heart Failure (member). Prof. Camm was awarded the ESC Gold Medal in 2005 and the British Cardiovascular Society Mackenzie Medal in 2008. He has authored or co-authored more than 1,150 peer-review papers and edited/authored more than 30 books.



North Ridge Executive Wellness, Raleigh, NC

Dr. Kevin Campbell is an internationally recognized cardiologist and is a leader in digital medicine, who trained in clinical cardiac electrophysiology at Duke Medical Center. Dr. Campbell has practiced clinical electrophysiology for 17 years and has published numerous papers as well as authored two books. Dr. Campbell is an on-air medical expert for national television outlets such as CBS, Fox News Channel, MSNBC and CNN. He is a contributor for U.S. News and World Report, Forbes and the Washington Examiner.



Cleveland Clinic, Cleveland, OH

Dr. Chung is a staff cardiologist in the Section of Pacing and Electrophysiology, The Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Cleveland Clinic, specializing in cardiovascular disease and clinical cardiac electrophysiology. She received her medical degree from Washington University School of Medicine and completed her internship, residency and postdoctoral fellowship in research and cardiology at Jewish Hospital of the Washington University School of Medicine, and her cardiac electrophysiology fellowship from Barnes Hospital, Washington University School of Medicine. Dr. Chung has been the principal investigator or co-investigator of several important clinical trials studying atrial fibrillation, supraventricular and ventricular arrhythmias, cardioversion, pacemaker and defibrillator therapy, biventricular pacing for heart failure and catheter ablation approaches.




Cardiovascular Center Bad Neustadt, Bad Neustadt, Germany

Prof. Deneke is director of Heart Center Bad Neustadt, focusing on catheter ablation of complex atrial and ventricular arrhythmias. This includes evaluating multiple novel ablation devices and techniques to treat atrial fibrillation and LAA occlusion/ligation program using different devices and technologies. The center is involved in many single and multicenter studies in the field of arrhythmia treatment and catheter ablation. The members of the EP team have been actively publishing their clinical science findings for several years. In addition, Prof. Deneke is a teacher for rhythmology and cardiology at the Ruhr-University Bochum and is involved in numerous educational sessions for young and experienced electrophysiologists throughout Germany and Europe.



Cardiovascular Center Aalst, Aalst, Belgium

Dr. De Potter graduated in 2001 from the University of Leuven in Belgium and trained as a cardiologist in Aalst and Ghent University until 2007, and as an electrophysiologist in Barcelona and Hamburg until 2009. Since 2009, he joined the Cardiovascular Center Aalst, Belgium, where he currently serves as associate director, clinically active within the arrhythmia unit of the department. He has focused on developing a multi-modallity imaging approach to support complex arrhythmia treatment, using and combining existing and experimental technologies such as intracardiac echography, 3D mapping/navigation and rotanional angiography. This has resulted in the arrhythmia unit becoming one of few European training centers for ventricular tachycardia ablation and the only center worldwide for training physicians on a minimal radiation workflow for atrial fibrillation ablation. As a spin-off, this imaging expertise has been translated to the structural heart program that has also resulted in the arrhythmia unit being selected as a training site for LAA closure and a study site for existing and novel devices for LAA closure.




Albert Einstein College of Medicine at Montefiore Hospital, Bronx, NY

Dr. DiBiase is section head of Electrophysiology and director of Arrhythmia Services at the Albert Einstein College of Medicine at Montefiore Medical Center. He is also a senior researcher at the Texas Cardiac Arrhythmia Institute at St. David’s Medical Center, Austin, Texas, and an assistant professor at the University of Foggia, Italy, where he completed the PhD program in cardiovascular physiopathology in November 2010. In addition, he is an adjunct associate professor at the University of Texas at Austin's department of Biomedical Engineering. Dr. Di Biase is committed to improving patient care through dedicated clinical practice associated to cutting-edge clinical research. Dr. Di Biase’s research has a specific emphasis on catheter ablation of atrial fibrillation and ventricular arrhythmias performed either manually or with robotic catheter navigation. Additionally, his research focuses on heart failure, particularly cases treated with cardiac resynchronization therapy devices. Dr. Di Biase has authored more than 350 publications and is presented at many national and international conferences as invited speaker.




Massachusetts General Hospital, Boston, MA

Dr. Ellinor is a Professor of Medicine at Harvard Medical School, director of Cardiac Arrhythmia Service at Massachusetts General Hospital (MGH) and an associate member at the Broad Institute. Dr. Ellinor’s research work has focused on identifying the molecular basis of atrial fibrillation. His research laboratories are located in the Cardiovascular Research Center at MGH and at the Broad Institute of Harvard and MIT. Dr. Ellinor currently helps to lead the AF and Gen Consortium, an international group of investigators studying the genetics of atrial fibrillation. Over the past 15 years, he has been continuously funded by the NIH, and has received an Established Investigator Award from the AHA; he is a principal investigator on a Transatlantic Research Network sponsored by the Foundation Leducq. Dr. Ellinor is a member of the American Heart Association, the Heart Rhythm Society and the American Society of Clinical Investigation.




U.S. Food and Drug Administration, Silver Spring, MD

Dr. Farb is a medical officer and senior reviewer in the Division of Cardiovascular Devices at FDA’s Center for Devices and Radiological Health (CDRH). He is a graduate of Dartmouth College (BA) and Cornell University Medical College (MD). He completed an internship and residency in internal medicine, a one-year residency in anatomic pathology, and a fellowship in clinical cardiology at The New York Hospital – Cornell University Medical Center. Following a fellowship in cardiovascular pathology at The Armed Forces Institute of Pathology (AFIP), he served as a staff cardiovascular pathologist at AFIP with research interests in and publications on coronary atherosclerosis and mechanisms of thrombosis, coronary artery interventions, and structural heart disease. He joined the FDA in 2004, where he has concentrated on clinical study development for interventional cardiology, structural heart, and peripheral vascular devices.




U.S. Food and Drug Administration, Silver Spring, MD

Mark Fellman, branch chief of the Cardiac Electrophysiology Devices Branch (CEDB) at the Food and Drug Administration and CEDB is responsible for premarket reviews of new marketing applications and investigational studies for cardiac ablation devices, diagnostic catheters, and advanced mapping systems. Mr. Fellman is a biomedical engineer, with 11 years of regulatory experience in therapeutic and diagnostic electrophysiology devices and clinical studies.




Massachusetts General Hospital, Boston, MA

Dr. Gurol, a vascular neurologist and researcher at Massachusetts General Hospital and Harvard Medical School, is an international expert on cerebral small vessel diseases of the elderly such as cerebral amyloid angiopathy, conditions that increase the risk of both hemorrhagic and ischemic cerebral events in affected individuals. He uses advanced neuroimaging techniques to clarify the molecular mechanisms of these microangiopathies and develop methods to stratify hemorrhagic risk. Dr. Gurol’s clinical focus is stroke prevention in the high-risk patient, i.e. patients with a hemorrhage prone cerebral small vessel disease as well as concomitant high embolic risk such as atrial fibrillation.




William Beaumont Hospital, Royal Oak, MI

Dr. Haines is the director of the Heart Rhythm Center, Electrophysiology Services, at William Beaumont Hospital. Dr. Haines graduated from the University of Rochester School of Medicine and Dentistry and completed his postgraduate training at the Medical Center Hospital of Vermont. Fellowships were completed at the University of Virginia Hospital. From 1986 to 2003, Dr. Haines served in various professor of medicine positions at the University of Virginia Hospital. He was also the co-director of the Cardiac Electrophysiology Laboratory at that hospital for over 13 years before joining the staff at Beaumont Hospital in Michigan. Dr. Haines’ expertise centers on using the latest technology to treat arrhythmias, as well as performing other cardiac procedures such as ablations, pacemakers and implantable cardiac defibrillators (ICD). He has a strong research interest in complex supraventricular arrhythmias and atrial fibrillation. In addition, Dr. Haines is the recipient of numerous grants and awards and serves on various national committees.




Central Hospital University of Bordeaux, Bordeaux, France

Prof. Haïssaguerre teaches at the Hôpital Cardiologique du Haut-Lévêque, Bordeaux-Pessac, and is the director of the Electrophysiology and Heart Modeling Institute LIRYC. He has an outstanding national and international scientific reputation. His scientific and clinical work focuses on cardiovascular electrophysiology, particularly on cardiac fibrillation. He is best known for his remarkable contributions in the area of atrial fibrillation ablation. He was the first to detect the importance of pulmonary vein triggers and drivers in the genesis of atrial fibrillation. In addition, he was first to propose the technique of pulmonary vein isolation, which underlies current methods used throughout the world for atrial fibrillation cure. His team has also demonstrated that Purkinje cells were the main triggers of human ventricular fibrillation, with or without heart disease.




Massachusetts General Hospital, Boston, MA

Dr. Heist is an Associate Professor of Medicine at Harvard Medical School and an associate physician in cardiology and cardiac electrophysiology at Massachusetts General Hospital (MGH). He is the program director for the Clinical Cardiac Electrophysiology Fellowship at MGH. Dr. Heist received his MD and PhD degrees from Stanford University School of Medicine, and received an MMSc degree from the Harvard/MIT Health Sciences Training Program. He completed his Internal Medicine Residency at UC San Francisco, and he then completed fellowships in both cardiovascular disease and clinical cardiac electrophysiology at MGH. His clinical and research interests focus on catheter ablation of cardiac arrhythmias including atrial fibrillation (AF), supraventricular tachycardia (SVT) and ventricular tachycardia (VT), as well as implantation and follow-up of cardiac device therapy including pacemakers, implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT) devices. He has published more than 150 papers on these topics, and is frequently invited to give educational lectures on these subjects at major national and international meetings.




Texas Cardiac Arrhythmia Institute, Austin, TX

Dr. Horton is an electrophysiologist at the Texas Cardiac Arrhythmia Institute. Now among the leading physicians in his field, Dr. Horton’s accomplished career in electrophysiology can be traced back to a difficult case he experienced as a young doctor during his internship. It was a patient who had been experiencing frequent, unexplained blackouts. The cause eluded the medical team until, finally, heart tracing revealed the problem to be a subtle rhythm disturbance. Frustrated by the difficulty of the diagnosis, Dr. Horton learned all he could about electrophysiology. It would become his specialty, and the man with the difficult diagnosis would become his first ablation patient. Dr. Horton earned his medical degree at the University of Texas Southwestern Medical School in Dallas, where he also completed a fellowship in cardiac electrophysiology. Also at UT Southwestern Medical School, Division of Cardiology, he has served as an assistant professor in internal medicine. He is a recipient of the Southwestern Medical Foundation Scholarship for Academic Excellence and the Rotary International Fellowship for Study Abroad at the University of Heidelberg, Germany, in the field of medicine.




Boston University Medical Center, Boston, MA

Dr. Hylek is a professor of medicine and director of the Thrombosis and Anticoagulation Service at Boston University Medical Center. She earned her medical degree at the University of Pittsburgh and received her internal medicine training at Massachusetts General Hospital and Harvard Medical School. Research areas include arterial (stroke) and venous thrombosis, anticoagulant therapies, and atrial fibrillation. Recent investigations have included the role of biomarkers in atrial fibrillation related stroke, factors associated with major hemorrhage and antithrombotic therapy, and the efficacy and safety of novel oral anticoagulant drugs. She has served on the executive steering committees for international clinical trials and national registries, event adjudication committees, and data safety monitoring boards. She is a section editor for Thrombosis and Haemostasis, and a member of the International Society of Thrombosis and Haemostasis Executive Committee for World Thrombosis Day.




Central Hospital, University of Bordeaux, France

Pierre Jaïs, a professor at the Cardiology Hospital, Pessac, France, working with Michel Haïssaguerre in the Rhythmolgy & Cardiac Stimulation Department, co-manages the LIRYC Institute (Electrophysiology and Heart Modeling Institute) and the MUSIC EQUIPEX. Both aim to improve knowledge and treatments of electrical dysfunctions of the heart with an extra focus on imaging for MUSIC. Dr. Jaïs is a regular contributor to national and international symposia and has written more than 400 articles, mainly on electrophysiology and RF catheter ablation, particularly focusing on atrial arrhythmias. He is currently working on catheter ablation for atrial and ventricular arrhythmias with special focus on advanced imaging integration and modeling to guide ablation procedures.




University of Michigan, Ann Arbor, MI

Dr. Jalife is the Cyrus and Jane Farrehi Professor of Cardiovascular Research; Professor of Internal Medicine and Molecular and Integrative Physiology, University of Michigan Medical School; and co-director of the University of Michigan Center for Arrhythmia Research. He completed his medical degree at the National University of Mexico in 1972. After clinical training in Spain, he conducted postdoctoral research in Pharmacology at the National Institute of Cardiology in Mexico, Upstate Medical University, and at the Masonic Medical Research Laboratory in Utica, New York. He joined the Department of Pharmacology at Upstate Medical University as a member of the faculty in 1980 and became chairman of the department in 1988. He has been the recipient of various honors and awards, including the 2001 American College of Cardiology Distinguished Scientist, the 2009 Heart Rhythm Society’s Distinguished Scientist Award, the 2010 Mirowski Award for Excellence in Clinical Cardiology and Electrophysiology, and in 2015 he also received the Doctor Honoris Causa from the University of Valencia, Spain. Dr. Jalife was recruited to his present position at the University of Michigan in 2008.




St. Vincent’s Hospital, Dublin, Ireland

Prof. Keane, director of the Cardiac Arrhythmia Service at St. Vincent’s University Hospital, Dublin, received his training at Guy’s Hospital, London, Erasmus University Hospital, Rotterdam, The Netherlands and Massachusetts General Hospital, Boston, Massachusetts, where he subsequently became director of Interventional Cardiac Electrophysiology. He is internationally recognized for his expertise in catheter ablation for cardiac arrhythmia, focusing on atrial fibrillation. He is a member of the Heart Rhythm Society, European Cardiac Arrhythmia Society, European Heart Rhythm Association, European Society of Cardiology, Royal College of Physicians of Ireland, Royal Society of Medicine, Irish Cardiac Society and is chair of the EP Subgroup of the Irish Cardiac Society.




Korea University Medical Center, Seoul, Korea

Dr. Kim is a Professor of Medicine and director of the Cardiac Arrhythmia Center at Korea University, Seoul, Korea. He completed his postgraduate training in internal medicine at Korea University Medical Center, fellowship training in cardiology and cardiac electrophysiology at Korea University, and research fellowship training at Cedars-Sinai Medical Center, Los Angeles. Dr. Kim joined the faculty in the Department of Medicine-Cardiology at the University of Korea, where he established the training and research program in clinical cardiac electrophysiology. He has participated in many professional societies’ scientific-program development and consensus documents. His principal research interests are catheter ablation of atrial fibrillation and ventricular tachycardia, and mapping of underlying mechanisms of various tachyarrhythmias.




Northwestern Memorial Hospital, Chicago, IL

As the medical director of Cardiac Electrophysiology at Northwestern Memorial Hospital since November 2009, Dr. Knight remains clinically active with a broad range of clinical and research interests in the field of heart rhythm disorders. These interests range from catheter ablation for complex arrhythmias, such as atrial fibrillation, to fundamental issues related to the basic mechanisms of various types of heart rhythm disorders, and the use of imaging in the electrophysiology laboratory to guide ablation procedures and device implantation. He is involved in several multicenter clinical trials that are evaluating novel ablation tools and implantable devices, including a totally subcutaneous implantable defibrillator. He has coauthored more than 250 scientific papers and is on the editorial board of several high-impact medical journals.




Hirslanden Heart Center, Zurich, Switzerland

From 1998 to 2006, Prof. Kottkamp headed the Department of Electrophysiology at the Heart Center Leipzig in Germany. Since 2006, he has served as head of Department of Electrophysiology at Clinic Hirslanden in Zurich, Switzerland. Prof. Kottkamp’s research focuses on catheter ablation of supraventricular and ventricular arrhythmias with special emphasis on ablation of atrial fibrillation. He has been published in more than 150 international journals and monographs, and serves on the editorial boards of the Journal of Cardiovascular Electrophysiology and Heart Rhythm. In his clinical work, Prof. Kottkamp is dealing with all aspects of interventional cardiac electrophysiology, from catheter ablation to implantation of PM, ICD and CRT.




Lankenau Hospital, Wynnewood, PA

Dr. Kowey, a graduate of St. Joseph’s University and University of Pennsylvania School of Medicine in Philadelphia, completed residency training in internal medicine at Pennsylvania State University, and was a fellow in cardiovascular medicine and research at Harvard University School of Public Health, Peter Bent Brigham Hospital and West Roxbury VA Hospital, all in Massachusetts. After training, he joined the faculty at the Medical College of Pennsylvania as director of the CCU and Arrhythmia Program, and rose to the rank of full professor. He went on to become chief of the Division of Cardiovascular Diseases at Lankenau Hospital and the Main Line Health Systems, where he is the William Wikoff Smith Chair in Cardiovascular Research. He also is a professor of medicine and clinical pharmacology at Jefferson Medical School.




St. Georg Hospital, Hamburg, Germany

Dr. Karl-Heinz Kuck is director of Cardiology of Allegemienes Krankenhaus St. Georg, Hamburg, Germany. Dr. Kuck has served the head of the 2nd Medical Department (Cardiology) of the St. Georg Hospital in Hamburg, Germany, since September 1, 1994. Dr. Kuck has served as the temporary head of the Department of Cardiology of the UHE in Hamburg, Germany, and assistant professor at the Department of Cardiology of the UHE in Hamburg, Germany. Dr. Kuck has served on the board of the European Heart Rhythm Association (EHRA) and as EHRA president.




University of Kansas Hospitals, Kansas City, MO

Dr. Lakkireddy graduated from Osmania Medical College, Hyderabad, India. He completed his residency at St. Luke’s Hospital, University of Missouri at Kansas City, and finished a cardiology fellowship at Creighton University, Omaha, Nebraska. He then completed another fellowship in clinical cardiology at the Cleveland Clinic Foundation, Cleveland, Ohio. Dr. Lakkireddy’s clinical interests include cardiac electrophysiology, complex arrhythmia management, radiofrequency ablation (AFIB/SVT/VT), cardiac device implantation and extraction, cardiac resynchronization therapy in heart failure, congenital cardiac rhythm disorders, long QT, hypertrophic cardiomyopathy, Brugada Syndrome and sudden cardiac death.




Massachusetts General Hospital, Boston, MA

Dr. Mansour is an Associate Professor in Medicine at Harvard Medical School. He is also director of the Atrial Fibrillation Program and the inaugural incumbent of the Jeremy Ruskin and Dan Starks Endowed Chair in Cardiology at Massachusetts General Hospital. He is an active clinical consultant in all aspects of heart rhythm disorders, including atrial fibrillation, ventricular tachycardia, supraventricular tachycardia, bradycardia and other abnormal rhythms. Dr. Mansour performs a large number of catheter ablation procedures, and implants pacemakers and defibrillators to treat different arrhythmias. He has published extensively in the field of cardiac arrhythmia, specifically the area of atrial fibrillation. Additionally, Dr. Mansour is involved in cutting-edge research and currently participating in the development of new catheters for the treatment of atrial fibrillation.




University of Pennsylvania Health Center, Philadelphia, PA

Dr. Marchlinski, Professor of Medicine and Director of Electrophysiology, University of Pennsylvania Health Care System, is a graduate of the University of Pennsylvania Medical School. He completed his postdoctoral internal medicine and cardiology/electrophysiology fellowship training at the Hospital of the University of Pennsylvania. He has authored or co-authored more than 400 original articles and more than 130 book chapters, reviews and editorials on a variety of topics in cardiac electrophysiology. His area of expertise is related to the characterization of the substrate and mechanisms of atrial and ventricular arrhythmias. His EP team has worked to improve localizing and ablation techniques for treatment of these arrhythmias.




University of Utah Hospitals & Clinics, Salt Lake City, UT

Dr. Marrouche received his medical degree from the Medical School at the University of Heidelberg in Germany, and has completed internships in infectious disease, pulmonary medicine and vascular surgery. Dr. Marrouche is a Professor of Medicine at the University of Utah, where he established and is the executive director of the Comprehensive Arrhythmia Research Center (CARMA) in addition to directing the Electrophysiology Laboratories and the Atrial Fibrillation Program. Dr. Marrouche’s research interests include the pathophysiology and new imaging modalities for treatment of atrial and ventricular arrhythmias.




Stanford University, Stanford, CA

Dr. Narayan, a Professor of Medicine at Stanford University, is a translational scientist in arrhythmia medicine, and the co-founder and co-director of the Stanford Arrhythmia Center, whose mission is to develop world-leading therapy based on patient-centered research for heart rhythm disorders. As director of electrophysiology research, Dr. Narayan has built a “bedside-to-bench-to-bed-side” program focused on mechanistic therapy for atrial and ventricular fibrillation. The foundations of this work are detailed patient studies, computational analyses, bioengineering solutions and other physiological studies. This work led to novel computational mapping and the discovery of rotational drivers (rotors) for human cardiac fibrillation, as now confirmed by optical mapping in human hearts and several independent clinical techniques.




Texas Cardiac Arrhythmia Institute, Austin, TX

Dr. Andrea Natale received his degree in medicine and surgery in 1985 from the Universita’ degli Studi of Firenze, Italy, and board certifications from the American Board of Internal Medicine (Internal Medicine, Cardiovascular Disease and Clinical Cardiac Electrophysiology). He is the executive medical director of the Texas Cardiac Arrhythmia Institute at St. David’s Medical Center, Austin, Texas, and the national medical director of Cardiac Electrophysiology for HCA Healthcare. A dedicated researcher and a pioneer, Dr. Natale focuses on innovative advances in the treatment of atrial fibrillation. He founded a circumferential ultrasound pulmonary vein-ablation system to correct atrial fibrillation and performed the procedure on the world’s first five patients. He also developed some of the current catheter-based cures for atrial fibrillation, and was the first cardiac electrophysiologist in the nation to perform percutaneous epicardial radiofrequency ablation, which is a treatment for people who fail conventional ablation. Recently, he was awarded the prestigious 2017 Eric N. Prystowsky Advocate for Patients Award for “outstanding service to and contributions for the benefit of Afib patients and their families.” Dr. Natale has been an invited speaker at hundreds of symposia and conferences around the world. Moreover, he has authored numerous published articles on pacing and electrophysiology in high-impact peer-reviewed journals, and served on the editorial boards of several major medical journals. Additionally, he is the editor-in-chief of the Journal of Atrial Fibrillation.




Montreal Heart Institute Research Center, Montreal, Quebec, Canada

Dr. Nattel is the Paul-David Chair in Cardiovascular Electrophysiology at the University of Montreal and director of the Electrophysiology Research Program at the Montreal Heart Institute, where he practices clinical cardiology. He is editor-in-chief of the Canadian Journal of Cardiology and associate editor of Cardiovascular Research. He is on the editorial board of numerous journals, including Circulation Research, JACC, Circulation Arrhythm Electrophysiol, Nature Rev Cardiol and JACC Clin Electrophysiol. His research focuses on mechanisms of cardiac bioelectricity, particularly relating to atrial fibrillation substrates and determinants, proarrhythmia, cardiac remodeling, ion channel molecular physiology and mechanisms of drug action. His lab uses a wide range of molecular, cellular, whole animal and theoretical methods to gain insights into clinically relevant basic mechanisms and identify novel therapeutic targets. He has published more than 600 peer-reviewed papers and has an h index of 121.



Na Homolce Hospital, Prague, Czech Republic

Dr. Neuzil received his Doctor of Medicine from Charles University, Prague, in 1987, and his PhD in 2001. He did his residency in internal medicine at General Hospital Charles University, Prague, Czech Republic, from 1989—1991 and a fellowship in cardiology Heart Centrum, Bad Krozingen, from 1991—1993. He worked at Beth Israel Deaconnes Medical Center (1997, 1998) and Massachusetts General Hospital (1998—2000). Dr. Neuzil is the director of cardiac arrhythmia service Na Homolce Hospital, Prague, since 2004, where he became head of cardiology in 2009. He is the director of the animal laboratory at Charles University, since 2006, and an associate professor, 2007. He was the director of Cardiac Arrhythmias Foundation, Prague, from 2005—2007, and is a consultant at the Technology School, Prague, since 2005. Dr. Neuzil’s achievements include the development of esophageal temperature probe, research in robotic cardiac catheterization, research in electromechanical robotic catheterization system Sensei and electromagnetic navigation Niobe, and research in balloon technology in catheter ablation technology, mainly laser energy. He is the editor of the journal Practicioner, a fellow of the European Society of Cardiology and a member of European Heart Rhythm Association and Heart Rhythm Society.



Mayo Clinic, Rochester, MN

Dr. Packer is a Professor of Medicine, director of Interventional Cardiac Electrophysiology Research Laboratories, and a consultant in the Division of Cardiovascular Diseases, Department of Internal Medicine, at Mayo Clinic, Rochester, MN. He is the director of both the Heart Rhythm Services and the Translational Electrophysiology Research Laboratory. Dr. Packer is recognized with the academic rank of the John M. Nasseff, Sr., Professor in Cardiovascular Diseases, and is internationally known in cardiac electrophysiology. Dr. Packer received the MD degree at the University of Utah and completed an internship, residency and fellowship at Duke University, where he was on staff before coming to Mayo. His honors and awards include the Distinguished Service Award from Brigham Young University. Dr. Packer is active in the Heart Rhythm Society where he is a past president and member of the board of trustees. He also has served on National Heart, Lung, and Blood Institute work groups on atrial fibrillation.




Silicon Valley Cardiology, Palo Alto, CA

Dr. Patrawala is a San Francisco Bay Area native who grew up in San Jose before attending UC Davis, where he obtained his BS in 1990 with High Honors. He attended UCLA Medical School, graduating in 1994 and was elected to the Alpha Omega Alpha Honor Society. Dr. Patrawala completed his internship and residency at Stanford Hospital, before returning to UC Davis for his cardiology fellowship, where he was the chief fellow. Following this, he returned to Stanford where he completed his training in cardiac electrophysiology. He joined Silicon Valley Cardiology in 2001 and practices all aspects cardiac electrophysiology. He has a special interest in ablation of atrial fibrillation and has performed more than 2,000 AF ablations. He is the current chair for the Palo Alto Medical Foundation Cardiac Electrophysiology Department and is the medical director for the Sequoia Hospital Heart and Vascular Institute.




Ministry of Health of the Russian Federation, Novosibirsk, Russia

Dr. Pokushalov holds the title of deputy director and head of the Interventional Cardiology Center (Arrhythmia Department and EP Laboratory, Endovascular Surgery Department) of the E. Meshalkin National Medical Research Center. Since the completion of his medical training, he has devoted all his professional time and effort to clinical cardiac electrophysiology, including both clinical and scientific activities serving as the primary operator in the electrophysiology laboratory, collecting and analyzing clinical data, initiating inner clinical studies, and follow-up. He has performed about 2,000 catheter-based ablation procedures, including postdiagnostic testing, and about 400 ICD procedures including programming. Since 2005, Dr. Pokushalov has taken part as a principal investigator and co-investigator in more than 30 international multicenter clinical studies.




The Care Group, St. Vincent Hospital, Indianapolis, IN

Dr. Prystowsky is a practicing cardiologist with St. Vincent Medical Group and director of the Cardiac Arrhythmia Service, St. Vincent Hospital, Indianapolis, IN. He is also a consulting Professor of Medicine at Duke University Medical Center. Dr. Prystowsky is a graduate of Pennsylvania State University and the Mt. Sinai School of Medicine. He completed his internal medicine training at Mt. Sinai Hospital, New York City, and his training in cardiology and clinical electrophysiology at Duke University Medical Center, Durham, NC. From 1979 to 1986, Dr. Prystowsky was a full-time faculty member at the Indiana University School of Medicine, where he was director of the Electrophysiology Laboratory. In 1986, he returned to Duke University as Professor of Medicine and director of the Cardiac Arrhythmia Center. He joined St. Vincent in 1988. In addition to co-authoring two textbooks, "Cardiac Arrhythmias: An Integrated Approach for the Clinician" and "Clinical Electrophysiology Review," Dr. Prystowsky has also authored more than 700 publications concerning cardiac arrhythmias. He is the editor-in-chief of The Journal of Cardiovascular Electrophysiology and is also on the editorial board of 15 journals.




Mount Sinai Medical Center, New York, NY

Dr. Reddy, director of Cardiac Arrhythmia Services for Mount Sinai Hospital and Mount Sinai Health System, and The Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology at Icahn School of Medicine at Mount Sinai, is one of the nation’s premier cardiac electrophysiologists. He leads a team of physician-scientists who are developing and testing advanced therapies for cardiac arrhythmias, including atrial fibrillation and ventricular tachycardias, the most common cause of sudden cardiac death. Dr. Reddy’s pioneering clinical research is changing the way cardiac patients are treated and cured. Under his leadership, Mount Sinai is the lead investigator on several multinational clinical trials exploring new arrhythmia procedures and technologies. Moreover, in 2014, he implanted inside a patient’s heart the world’s first miniature leadless pacemaker in the United States at Mount Sinai Hospital.




Massachusetts General Hospital, Boston, MA

Dr. Ruskin is Professor of Medicine at Harvard Medical School and Founder and Director Emeritus of the Cardiac Arrhythmia Service at Massachusetts General Hospital. In 1978, Dr. Ruskin founded the Cardiac Arrhythmia Service and Clinical Cardiac Electrophysiology Fellowship Training Program at Massachusetts General Hospital. This was the first subspecialty service dedicated to the care of patients with cardiac arrhythmias and the first subspecialty-training program in cardiac electrophysiology in New England and one of the first in the United States. Dr. Ruskin has been responsible for the training and mentorship of more than 115 clinical and research fellows in the subspecialty of cardiac arrhythmias, many of whom are in leadership positions at academic centers throughout the world. His research focuses on atrial fibrillation, sudden cardiac death, and new approaches to the prevention of cardiac fibrosis. Dr. Ruskin is the recipient of the 1997 Michel Mirowski Award for Excellence in Clinical Cardiology and Electrophysiology, the 2002 Heart Rhythm Society Pioneer in Pacing and Electrophysiology Award and the 2015 KCHRS Pioneer in Electrophysiology Award. He was named the inaugural incumbent of the Omran Alomran Endowed Chair in Cardiology at Massachusetts General Hospital in 2016.




Vancouver General Hospital, Vancouver, British Columbia, Canada

Dr. Saw is an interventional cardiologist at Vancouver General Hospital (VGH) with joint appointment at St. Paul’s Hospital. She is a Clinical Professor of Medicine at the University of British Columbia, and director of the Interventional Cardiology Fellowship Program at VGH. Dr. Saw is a pioneer and leader in research and management of spontaneous coronary artery dissection (SCAD), and is the principal investigator of the Canadian Institutes of Health Research-funded multicenter prospective Canadian SCAD Study, and the Heart and Stroke Foundation-funded Canadian SCAD Genetic Study. Other research interests include LAA closure, non-atherosclerotic coronary artery disease, antiplatelet therapy, percutaneous coronary intervention, carotid artery stenting, peripheral arterial disease and intervention. She is also the principal investigator of PRYME, NACAD, SAFER-SCAD, Canadian WATCHMAN Registry, TAP-CABG, and ELAPSE studies.




University of Maastricht, Maastricht, The Netherlands

Prof. Schotten studied medicine at the universities of Aachen, Glasgow and Valetta. After four years of training in cardiology at the University Hospital of Aachen, he defended his thesis “Mechanisms of Atrial Paralysis in Atrial Fibrillation” at Maastricht University. In 2011, he was appointed professor of cardiac electrophysiology at the Department of Physiology in Maastricht. His research program ranges from the molecular and cellular investigations to studies on the organ and systemic level. He currently works on cellular and integrated actions of antiarrhythmic drugs, the development of substrates for the perpetuation of atrial fibrillation, invasive and noninvasive classification of atrial fibrillation, interaction between atrial fibrillation and activation of the coagulation system, and three-dimensional computer models. Prof. Schotten is principle investigator or coordinator of numerous national and international research networks and has been member of the European task force for the development of the ESC guidelines for management of atrial fibrillation in 2010 and 2016.




Massachusetts General Hospital, Boston, MA

Dr. Singer is Professor of Medicine at Harvard Medical School and Professor in the Department of Epidemiology at Harvard School of Public Health. At Massachusetts General Hospital, he is chief of the Clinical Epidemiology Unit, associate chief for research in the General Medicine Division, and director of the General Medicine Research Fellowship. Dr. Singer is widely recognized for his research contributions in clinical epidemiology and preventive medicine, in particular, the prevention of stroke in atrial fibrillation. He received the 2003 John Eisenberg Award from the National Society for General Internal Medicine for Career Achievements in Research, and the 2008 C. Miller Fisher Award from the Massachusetts chapter of the American Stroke Association/American Heart Association for his contributions to stroke research.




Centro Cardiologico Monsino-University of Milan, Milan, Italy

Prof. Tondo is a professor of cardiology and director of the Cardiac Arrhythmia Research Center of Centro Cardiologico Monzino-University of Milan. A world-recognized leader in the field of electrophysiology, Prof. Tondo is a dedicated clinician and researcher. He has been director of the Cardiac Arrhythmia and Heart Failure Research Institute, San Camillo-Forlanini Hospital, and co-director of the Electrophysiology Experimental Laboratory, Catholic University of Sacred Heart, in Rome, Italy. Prof. Tondo has been an invited lecturer at more than 100 symposiums and conferences around the world and is the author or co-author of hundreds of published articles on pacing and electrophysiology. Since 2007, he is a visiting professor at Harvard Medical School in Boston. Prof. Tondo and his team focus on innovative advances in the treatment of atrial fibrillation through the most advanced technologies such as robotic devices and specialized ablation catheters. He is a regular member of North American Society of Pacing and Electrophysiology and Italian Society of Arrhythmology.




Johns Hopkins University, Baltimore, MD

Dr. Trayanova is the Murray B. Sachs Professor in the Department of Biomedical Engineering and Institute for Computational Medicine at Johns Hopkins University. The research in Dr. Trayanova’s Computational Cardiology Lab centers on understanding the normal and pathological electrophysiological and electromechanical behavior of the heart using multiscale simulation approaches that include biophysically detailed representations of cellular and subcellular processes and image-based descriptions of the geometry and structure of the heart. Research projects focus on the mechanisms for cardiac arrhythmogenesis and cardiac electromechanical interactions. Importantly, a large number of projects are devoted to the improvement of the clinical therapies of defibrillation, infarct-related ventricular ablation, and cardiac resynchronization therapy using a personalized approach.




University Hospitals of Cleveland, Cleveland, OH

Dr. Waldo is the Walter H. Pritchard Professor of Cardiology, and a Professor of Medicine and Biomechanical Engineering at Case Western University School of Medicine in Cleveland, Ohio. He has published more than 450 works in the field of cardiac electrophysiology, in which he has worked and helped to advance since its inception several decades ago. He has received numerous awards, including the Distinguished Scientist Awards from NASPE (now called HRS), and the American College of Cardiology. His extensive public service has included serving on NIH NHLBI study sections, and FDA advisory committees; president and trustee of NASPE, and editorial board of numerous journals in the field.




Loyola University Medical Center, Maywood, IL

Dr. Wilber is the George M. Eisenberg Professor of Medicine and director of the Electrophysiology Section and Cardiovascular Institute, Loyola University Medical Center. He was also the director of the Division of Cardiology at Loyola from 2001 until June of 2017. Dr. Wilber is a graduate of Northwestern University Medical School, and completed his medical residency at Northwestern University Medical Center. Dr. Wilber went on to complete a fellowship in Cardiovascular Disease at the University of Michigan and a fellowship in Clinical Cardiac Electrophysiology at the Massachusetts General Hospital. As director of Clinical Electrophysiology, Dr. Wilber remains an active clinician with focused interests in atrial fibrillation, ventricular tachycardia and sudden-death prevention. He has been named annually to Top Doctors in Chicago and the United States since 2001. Dr. Wilber is the author or coauthor of more than 500 original articles, book chapters and abstracts, and has served on the steering committee and executive committee for several multicenter clinical trials.